Delivery Order SPE2DB22D3016-SPE2DB25FAAF4

Award Date 10/8/24
Potential Completion Date 10/9/24
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $44,227.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJ (2-PK)ML, a pharmaceutical product, with a completion date of December 31, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This federal contract award, valued at $59,575.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567925565 TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, over the period ending on April 16, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $4,570.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, and has an ultimate completion date of January 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $23,535.80, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The delivery order is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of October 16, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp, a for-profit organization and major pharmaceutical distributor, will provide these medical products to support...
This federal contract award, with a value of $26,803.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for TALTZ 80 MG/ML AUTOINJECTOR, a pharmaceutical product, with a performance period through December 15, 2023. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This federal contract award, valued at $14,316.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a medication, with a completion date of February 19, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $14,421.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJ (2-PK)ML pharmaceutical products. AmerisourceBergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products...
This federal contract award is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $22,465.18 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has an ultimate completion date of May 31, 2024 and was awarded on May 30, 2024. It is a delivery order contract, with no set-aside designation....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $4,412.08 Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA). The contract is for the supply of the prescription medication TALTZ 80 MG/ML AUTOINJECTORML, with a performance period through May 13, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside. The company holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The contract has a ceiling value of $66,054.20 and is a Firm Fixed Price Delivery Order with a completion date of February 27, 2024. The...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAAF4
    Delivery Order

This federal contract award, valued at $50,324.34, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJ (2-PK)ML, a pharmaceutical product, with a period of performance through October 9, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other federal healthcare providers. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999 and $750,000, respectively, for delivering a comprehensive range of medical commodities to support government healthcare needs.

Generated 1/7/25, 11:30 AM